ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
팁소보 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 10억 8,000만 달러에서 2026년에는 11억 9,000만 달러에 이르고, CAGR 9.6%의 성장이 전망되고 있습니다. 지난 몇 년간 성장 요인으로는 IDH1 표적치료제 공급 부족, 급성골수성백혈병(AML) 및 담관암 발병률 증가, 기존 화학요법에 대한 의존도, 유전자 변이 검사에 대한 인식 부족, 전문 종양 클리닉에 대한 접근성 제한 등을 꼽을 수 있습니다.
팁소보 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 17억 달러에 이르고, CAGR은 9.3%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 새로운 경구 표적치료제 개발, 유전자 검사 및 맞춤의료 도입 확대, 병용치료 요법 확대, 종양학 연구에 대한 투자 증가, 병원 및 전문 클리닉 네트워크의 성장 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 급성골수성백혈병(AML) 및 담관암에 대한 표적치료제 도입 증가, 정맥 투여 대비 경구용 표적치료제 사용 확대, 병용요법 접근법 확대, IDH1 돌연변이 검사에 대한 인지도 향상, 맞춤 암치료에 대한 집중도 강화 등이 있습니다.
급성 골수성 백혈병의 유병률 증가는 향후 TIBSOVO 시장의 성장을 가속할 것으로 예측됩니다. 급성골수성백혈병(AML)은 혈액과 골수에 발생하는 악성도가 높은 암으로, 정상적인 혈액세포의 생성을 방해하고 면역기능을 저하시켜 전신 건강상태에 악영향을 끼치는 질환입니다. AML의 발병률 증가는 주로 전 세계 고령화 인구 증가에 기인합니다. AML은 주로 노년층에서 발병하며, 평균 수명의 연장으로 인해 이 질환의 가장 높은 위험 연령층에 도달하는 인구가 증가하고 있기 때문입니다. TIBSOVO는 IDH1 돌연변이를 가진 암세포를 선택적으로 표적화하여 비정상적인 세포 증식을 억제함으로써 급성골수성백혈병의 치료를 돕습니다. 이를 통해 질병의 진행을 지연시키고, 치료 반응성을 개선하며, 정상적인 혈액 세포 형성의 회복을 도와 생존율을 향상시킵니다. 예를 들어, 2023년 2월 호주의 비영리단체인 백혈병 재단이 발표한 보고서에 따르면 2022년부터 2035년까지 7,000명 이상의 어린이, 6,000명의 젊은 성인, 그리고 25세에서 65세 사이의 성인 10만 8,000명이 급성 림프성 백혈병(ALL), 급성 골수성 백혈병(AML), 비호지킨 림프종(AML) 급성골수성백혈병(AML), 비호지킨림프종 등 혈액암 진단을 받을 것으로 예측됩니다. 따라서 급성 골수성 백혈병의 유병률 증가가 TIBSOVO 시장의 성장을 견인하고 있습니다.
TIBSOVO 시장에서 활동하는 주요 기업들은 규제 당국의 승인 획득에 집중하여 시장에서의 입지를 확대하고, IDH1 변이 암 치료 분야에서 선도적 지위를 강화하기 위해 노력하고 있습니다. 규제 당국의 승인은 의약품이 특정 질환에 대한 판매 및 처방을 허용하는 보건 당국의 공식적인 승인입니다. 안전성과 유효성이 확인된 후 부여됩니다. 예를 들어, 2023년 10월 프랑스에 본사를 둔 제약사 세르비에 라보라투르(Servier Laboratoire)가 유럽위원회로부터 TIBSOVO(이보시데닙 정)의 승인을 받았습니다. 이로써 이 약은 유럽에서 치료하기 어려운 두 가지 암종에 대해 승인된 최초이자 유일한 IDH1 표적 치료제가 되었습니다. 이 약은 IDH1 R132 돌연변이가 있는 급성골수성백혈병(AML) 환자 중 표준 도입 화학요법을 받을 수 없는 환자에서 아자시티딘과의 병용요법 및 최소 1회 전신요법을 받은 후 같은 돌연변이가 있는 국소 진행성 또는 전이성 담관암 성인 환자의 단독요법으로 승인됐습니다. 로 승인되었습니다. 이번 희귀의약품 지정으로 미충족 수요를 해소하고 환자들에게 개선된 치료 옵션과 삶의 질을 제공할 수 있게 됐습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 세계 시장 경쟁 벤치마킹과 대시보드
제38장 주요 인수합병(M&A)
제39장 시장 잠재력이 높은 국가, 부문, 전략
제40장 부록
LSH
영문 목차
영문목차
Tibsovo is an oral targeted therapy mainly prescribed for adults with acute myeloid leukemia (AML) or cholangiocarcinoma who carry a specific mutation in the IDH1 gene. It works by inhibiting the mutated IDH1 enzyme, thereby lowering the levels of an abnormal metabolite that drives cancer cell growth. This action helps restore normal cell differentiation and slows disease progression.
The main product types of Tibsovo include tablets, capsules, combination therapy, and injectable forms. Tablets represent the oral solid dosage form of ivosidenib and are designed for convenient once-daily use. These products are administered via oral and intravenous routes and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. They are used in applications such as cancer treatment, acute myeloid leukemia management, chemotherapy, and targeted therapy, serving end users including hospitals, specialty clinics, research institutions, and homecare settings.
Tariffs have affected the tibsovo market by increasing costs of imported raw materials and active pharmaceutical ingredients (apis) required for oral targeted therapies. Segments such as tablets, capsules, and combination therapy products are particularly impacted, with regions like North America and Europe facing supply chain adjustments due to import duties. While tariffs may increase drug prices and production costs, they also encourage domestic manufacturing, innovation in apis, and localization of supply chains, ultimately strengthening regional production capabilities.
The tibsovo market research report is one of a series of new reports from The Business Research Company that provides tibsovo market statistics, including tibsovo industry global market size, regional shares, competitors with a tibsovo market share, detailed tibsovo market segments, market trends and opportunities, and any further data you may need to thrive in the tibsovo industry. This tibsovo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tibsovo market size has grown strongly in recent years. It will grow from $1.08 billion in 2025 to $1.19 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to limited availability of idh1-targeted drugs, growing prevalence of aml and cholangiocarcinoma, reliance on conventional chemotherapy, low awareness of genetic mutation testing, restricted access to specialized oncology clinics.
The tibsovo market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to development of novel oral targeted therapies, increasing genetic testing and personalized medicine adoption, expansion of combination treatment regimens, rising investment in oncology research, growth of hospital and specialty clinic networks. Major trends in the forecast period include rising adoption of targeted therapies for aml and cholangiocarcinoma, increasing use of oral targeted drugs over intravenous administration, expansion of combination therapy approaches, growing awareness of idh1 mutation testing, enhanced focus on personalized cancer treatment.
The increasing prevalence of acute myeloid leukemia is expected to propel the growth of the TIBSOVO market going forward. Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow that disrupts normal blood cell production, weakens immune function, and adversely affects overall health. The prevalence of acute myeloid leukemia is rising mainly due to the growing global aging population, as AML predominantly affects older adults, and increased life expectancy results in a larger population reaching the age group most at risk for this disease. TIBSOVO supports the treatment of acute myeloid leukemia by selectively targeting IDH1-mutated cancer cells, inhibiting abnormal cell proliferation, slowing disease progression, improving therapeutic response, and enhancing survival outcomes by helping restore normal blood cell formation. For instance, in February 2023, according to a report published by the Leukemia Foundation, an Australia-based non-profit organization, between 2022 and 2035, more than 7,000 children, 6,000 young adults, and 108,000 adults aged 25-65 are projected to be diagnosed with blood cancers, primarily including ALL, AML, and non-Hodgkin lymphoma. Therefore, the increasing prevalence of acute myeloid leukemia is driving the growth of the TIBSOVO market.
Major companies operating in the TIBSOVO market are concentrating on securing regulatory approvals to expand the drug's market presence and reinforce its leadership in treating IDH1-mutated cancers. Regulatory approvals are formal authorizations granted by health authorities that permit a drug to be marketed and prescribed for specific conditions after verifying its safety and efficacy. For example, in October 2023, Servier Laboratoires, a France-based pharmaceutical company, received approval from the European Commission for TIBSOVO (ivosidenib tablets), making it the first and only IDH1-targeted therapy authorized in Europe for two difficult-to-treat cancers. It is approved for use in combination with azacitidine for newly diagnosed AML patients with an IDH1 R132 mutation who are not eligible for standard induction chemotherapy, and as a monotherapy for adults with locally advanced or metastatic cholangiocarcinoma carrying the same mutation following at least one prior systemic therapy. This approval, supported by orphan drug designation, addresses significant unmet medical needs and offers patients improved treatment options and quality of life.
In December 2023, Servier Group, a France-based pharmaceutical company that markets TIBSOVO (ivosidenib tablets) as a targeted therapy for patients with IDH1-mutated cancers, acquired exclusive rights to develop, manufacture, and commercialize TIBSOVO from CStone Pharmaceuticals for $44 million. This acquisition is intended to strengthen Servier Group's presence in the fast-growing China and Singapore markets by securing exclusive rights to TIBSOVO, expanding its oncology portfolio with a precision therapy for IDH1-mutated cancers, and accelerating patient access to this innovative treatment in these strategic regions. CStone Pharmaceuticals is a China-based biopharmaceutical company focused on oncology drug development.
Major companies operating in the tibsovo market are Servier Laboratoires, Agios Pharmaceuticals
North America was the largest region in the tibsovo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tibsovo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the tibsovo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tibsovo market consists of sales of products including oral tablets, extended-release tablets, soft gel capsules, intravenous injection, and subcutaneous injection. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tibsovo Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses tibsovo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tibsovo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tibsovo market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Tablets; Combination Therapy
2) By Drug Administration: Oral Administration; Intravenous Administration
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By Application: Cancer Treatment; Acute Myeloid Leukemia; Targeted Therapy
5) By End User: Hospitals; Specialty Clinics; Research Institutions; Homecare Settings
Subsegments:
1) By Tablets: Oral Tablets; Extended-Release Tablets
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Adoption Of Targeted Therapies For Aml And Cholangiocarcinoma
4.2.2 Increasing Use Of Oral Targeted Drugs Over Intravenous Administration
4.2.3 Expansion Of Combination Therapy Approaches
4.2.4 Growing Awareness Of Idh1 Mutation Testing
4.2.5 Enhanced Focus On Personalized Cancer Treatment
5. Tibsovo Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Specialty Clinics
5.3 Research Institutions
5.4 Homecare Settings
5.5 Oncology Centers
6. Tibsovo Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Tibsovo Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Tibsovo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Tibsovo Market Size, Comparisons And Growth Rate Analysis
7.3. Global Tibsovo Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Tibsovo Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Tibsovo Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Tibsovo Market Segmentation
9.1. Global Tibsovo Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tablets, Combination Therapy
9.2. Global Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral Administration, Intravenous Administration
9.3. Global Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.1. Global Tibsovo Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Tibsovo Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Tibsovo Market
11.1. Asia-Pacific Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Tibsovo Market
12.1. China Tibsovo Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Tibsovo Market
13.1. India Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Tibsovo Market
14.1. Japan Tibsovo Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Tibsovo Market
15.1. Australia Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Tibsovo Market
16.1. Indonesia Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Tibsovo Market
17.1. South Korea Tibsovo Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Tibsovo Market
18.1. Taiwan Tibsovo Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Tibsovo Market
19.1. South East Asia Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Tibsovo Market
20.1. Western Europe Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Tibsovo Market
21.1. UK Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Tibsovo Market
22.1. Germany Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Tibsovo Market
23.1. France Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Tibsovo Market
24.1. Italy Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Tibsovo Market
25.1. Spain Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Tibsovo Market
26.1. Eastern Europe Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Tibsovo Market
27.1. Russia Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Tibsovo Market
28.1. North America Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Tibsovo Market
29.1. USA Tibsovo Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Tibsovo Market
30.1. Canada Tibsovo Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Tibsovo Market
31.1. South America Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Tibsovo Market
32.1. Brazil Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Tibsovo Market
33.1. Middle East Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Tibsovo Market
34.1. Africa Tibsovo Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Tibsovo Market, Segmentation By Product, Segmentation By Drug Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Tibsovo Market Regulatory and Investment Landscape
36. Tibsovo Market Competitive Landscape And Company Profiles
36.1. Tibsovo Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Tibsovo Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Tibsovo Market Company Profiles
36.3.1. Servier Laboratoires Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Agios Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
37. Global Tibsovo Market Competitive Benchmarking And Dashboard
38. Key Mergers And Acquisitions In The Tibsovo Market
39. Tibsovo Market High Potential Countries, Segments and Strategies
39.1 Tibsovo Market In 2030 - Countries Offering Most New Opportunities
39.2 Tibsovo Market In 2030 - Segments Offering Most New Opportunities
